Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

One wrong move — a little too much insulin or a forgotten dose — and ... risk of hypoglycaemia and partly covering the need ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

The University of California, San Francisco states that, as a general rule, 1 unit of rapid-acting insulin will process anywhere from 12 to 15 grams of carbohydrates. A bolus dose may also be used ...

In an awake individual, mild-to-moderate nocturnal hypoglycemia is easily corrected by ingesting a snack containing approximately 5 g of fast-acting carbohydrate ... the basal insulin, a bedtime ...

providing a background level of blood glucose control that can sometimes be topped up at mealtimes with fast-acting insulins. The results of the ONWARDS 2 trial of insulin icodec showed that it ...

In 1985, Novo Nordisk pioneered production of recombinant human insulin in yeast. In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by genetic engineering ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...